OPKO 800

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:advertising direct-to-consumer advertising
gptkbp:approves 2014
gptkbp:availability widely available in pharmacies
gptkbp:brand gptkb:OPKO_800
gptkbp:caseTypes Sildenafil citrate
gptkbp:chemicalFormula oral tablet
gptkbp:class PDE5 inhibitor
gptkbp:clinicalTrials ongoing research
demonstrated in studies
follow established protocols
Phase III trials completed
gptkbp:collaborations with academic institutions
gptkbp:competitors competes with other ED medications
gptkbp:contraindication nitrates
severe cardiovascular disorders
rarely serious
gptkbp:dosageForm 800 mg
gptkbp:drugInterdiction rapid absorption
gptkbp:endOfLife approximately 4 hours
gptkbp:enrollment varied age groups
adult males
gptkbp:evaluates high
gptkbp:formFactor tablet
gptkbp:healthcare available
important for safe use
https://www.w3.org/2000/01/rdf-schema#label OPKO 800
gptkbp:impact headache
nasal congestion
flushing
vision changes
dyspepsia
gptkbp:ingredients Sildenafil
gptkbp:insuranceAccepted may vary
gptkbp:interactsWith antihypertensives
alpha-blockers
gptkbp:is_available_in various dosages
gptkbp:is_monitored_by blood pressure recommended
gptkbp:is_used_in treatment of erectile dysfunction
gptkbp:mandates gptkb:pulmonary_arterial_hypertension
gptkbp:manufacturer gptkb:OPKO_Health,_Inc.
gptkbp:market yes
gptkbp:marketedAs brand name
gptkbp:nutritionalValue liver
gptkbp:offers varies by pharmacy
gptkbp:packaging blister pack
gptkbp:patentStatus patented
gptkbp:regulatoryCompliance subject to review
FDA_approved
gptkbp:requires true
gptkbp:research_focus erectile dysfunction treatments
gptkbp:route oral
gptkbp:safety use with caution in certain populations
gptkbp:safety_features generally well tolerated
gptkbp:services patient counseling required
gptkbp:storage room temperature
gptkbp:supplyChain managed by manufacturer
gptkbp:technology as needed basis
gptkbp:waterManagement urine